A detailed history of Neuberger Berman Group LLC transactions in Illumina, Inc. stock. As of the latest transaction made, Neuberger Berman Group LLC holds 143,623 shares of ILMN stock, worth $19.5 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
143,623
Previous 134,349 6.9%
Holding current value
$19.5 Million
Previous $14 Million 33.55%
% of portfolio
0.02%
Previous 0.01%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$105.28 - $135.9 $976,366 - $1.26 Million
9,274 Added 6.9%
143,623 $18.7 Million
Q2 2024

Nov 14, 2024

SELL
$101.05 - $133.57 $36,580 - $48,352
-362 Reduced 0.27%
134,349 $14 Million
Q2 2024

Aug 13, 2024

SELL
$101.05 - $133.57 $36,580 - $48,352
-362 Reduced 0.27%
134,349 $14 Million
Q1 2024

Nov 14, 2024

BUY
$127.73 - $147.2 $216,630 - $249,651
1,696 Added 1.28%
134,711 $18.5 Million
Q1 2024

May 13, 2024

BUY
$127.73 - $147.2 $17.2 Million - $19.8 Million
134,711 New
134,711 $18.5 Million
Q4 2023

Nov 14, 2024

SELL
$92.79 - $142.53 $123,781 - $190,135
-1,334 Reduced 0.99%
133,015 $18.5 Million
Q4 2023

Feb 09, 2024

BUY
$92.79 - $142.53 $11.9 Million - $18.3 Million
128,731 Added 3004.93%
133,015 $18.5 Million
Q3 2023

Nov 14, 2023

SELL
$128.91 - $192.44 $276,511 - $412,783
-2,145 Reduced 33.36%
4,284 $588,000
Q2 2023

Aug 11, 2023

SELL
$183.43 - $232.67 $130,051 - $164,963
-709 Reduced 9.93%
6,429 $1.21 Million
Q1 2023

May 12, 2023

BUY
$193.75 - $232.55 $57,543 - $69,067
297 Added 4.34%
7,138 $1.66 Million
Q4 2022

Feb 13, 2023

BUY
$187.24 - $242.74 $109,535 - $142,002
585 Added 9.35%
6,841 $1.38 Million
Q3 2022

Nov 15, 2022

BUY
$177.23 - $227.44 $283,568 - $363,904
1,600 Added 34.36%
6,256 $1.2 Million
Q2 2022

Aug 15, 2022

SELL
$181.58 - $368.0 $10.2 Million - $20.6 Million
-56,043 Reduced 92.33%
4,656 $861,000
Q1 2022

May 13, 2022

BUY
$303.87 - $423.8 $152,238 - $212,323
501 Added 0.83%
60,699 $20.8 Million
Q4 2021

Feb 11, 2022

BUY
$347.28 - $421.83 $1.25 Million - $1.52 Million
3,604 Added 6.37%
60,198 $22.6 Million
Q3 2021

Nov 12, 2021

SELL
$405.61 - $524.84 $147,642 - $191,041
-364 Reduced 0.64%
56,594 $22.5 Million
Q2 2021

Aug 13, 2021

BUY
$372.84 - $481.5 $2.93 Million - $3.79 Million
7,871 Added 16.03%
56,958 $26.5 Million
Q1 2021

May 13, 2021

BUY
$361.28 - $504.76 $244,947 - $342,227
678 Added 1.4%
49,087 $18.6 Million
Q4 2020

Feb 10, 2021

SELL
$292.7 - $370.96 $3.36 Million - $4.26 Million
-11,473 Reduced 19.16%
48,409 $17.8 Million
Q3 2020

Nov 12, 2020

BUY
$268.51 - $400.74 $220,715 - $329,408
822 Added 1.39%
59,882 $18.5 Million
Q2 2020

Aug 13, 2020

BUY
$256.46 - $373.01 $2.37 Million - $3.45 Million
9,252 Added 18.58%
59,060 $21.8 Million
Q1 2020

May 14, 2020

BUY
$209.2 - $335.53 $179,702 - $288,220
859 Added 1.75%
49,808 $13.6 Million
Q4 2019

Feb 12, 2020

SELL
$288.29 - $335.49 $264,073 - $307,308
-916 Reduced 1.84%
48,949 $16.2 Million
Q3 2019

Nov 13, 2019

BUY
$266.84 - $378.23 $78,184 - $110,821
293 Added 0.59%
49,865 $15.2 Million
Q2 2019

Aug 13, 2019

SELL
$300.59 - $368.15 $94,986 - $116,335
-316 Reduced 0.63%
49,572 $18.3 Million
Q1 2019

May 13, 2019

BUY
$272.57 - $321.18 $2.73 Million - $3.22 Million
10,013 Added 25.11%
49,888 $15.5 Million
Q4 2018

Feb 12, 2019

BUY
$272.46 - $366.54 $61,303 - $82,471
225 Added 0.57%
39,875 $12 Million
Q3 2018

Nov 13, 2018

BUY
$279.04 - $367.06 $166,028 - $218,400
595 Added 1.52%
39,650 $14.6 Million
Q2 2018

Aug 13, 2018

BUY
$228.17 - $292.07 $592,101 - $757,921
2,595 Added 7.12%
39,055 $10.9 Million
Q1 2018

May 08, 2018

BUY
$209.54 - $253.91 $6.18 Million - $7.49 Million
29,485 Added 422.72%
36,460 $8.62 Million
Q4 2017

Feb 14, 2018

BUY
$202.23 - $230.03 $321,747 - $365,977
1,591 Added 29.55%
6,975 $1.52 Million
Q3 2017

Nov 15, 2017

BUY
$172.3 - $213.93 $927,663 - $1.15 Million
5,384
5,384 $1.07 Million

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $21.4B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Neuberger Berman Group LLC Portfolio

Follow Neuberger Berman Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.